By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping
- PMID: 19006096
- DOI: 10.1002/jgm.1265
By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping
Abstract
Background: Duchenne muscular dystrophy (DMD), a severe neuromuscular disorder, is caused by protein-truncating mutations in the dystrophin gene. Absence of functional dystrophin renders muscle fibres more vulnerable to damage and necrosis. We report antisense oligomer (AO) induced exon skipping in the B6Ros.Cg-Dmd(mdx-4Cv)/J (4(CV)) mouse, a muscular dystrophy model arising from a nonsense mutation in dystrophin exon 53. Both exons 52 and 53 must be excised to remove the mutation and maintain the reading frame.
Methods: A series of 2'-O-methyl modified oligomers on a phosphorothioate backbone (2OMeAOs) were designed and evaluated for the removal of each exon, and the most effective compounds were then combined to induce dual exon skipping in both myoblast cultures and in vivo. Exon skipping efficiency of 2OMeAOs and phosphorodiamidate morpholino oligomers (PMOs) was evaluated both in vitro and in vivo at the RNA and protein levels.
Results: Compared to the original mdx mouse studies, induction of exon skipping from the 4(CV) dystrophin mRNA was far more challenging. PMO cocktails could restore synthesis of near-full length dystrophin protein in cultured 4(CV) myogenic cells and in vivo, after a single intramuscular injection.
Conclusions: By-passing the protein-truncating mutation in the 4(CV) mouse model of muscular dystrophy could not be achieved with single oligomers targeting both exons and was only achieved after the application of AO cocktails to remove exons 52 and 53. As in previous studies, the stability and efficiency of PMOs proved superior to 2OMeAOs for consistent and sustained protein induction in vivo.
(c) 2008 John Wiley & Sons, Ltd.
Similar articles
-
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288. J Gene Med. 2009. PMID: 19140108
-
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.Gene Ther. 2006 Oct;13(19):1373-81. doi: 10.1038/sj.gt.3302800. Epub 2006 May 25. Gene Ther. 2006. PMID: 16724091
-
Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide.J Gene Med. 2006 Feb;8(2):207-16. doi: 10.1002/jgm.838. J Gene Med. 2006. PMID: 16285002
-
Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.Nucleic Acid Ther. 2014 Feb;24(1):57-68. doi: 10.1089/nat.2013.0451. Epub 2013 Dec 31. Nucleic Acid Ther. 2014. PMID: 24380394 Review.
-
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.Hum Mutat. 2009 Mar;30(3):293-9. doi: 10.1002/humu.20918. Hum Mutat. 2009. PMID: 19156838 Review.
Cited by
-
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine.J Clin Med. 2018 Sep 19;7(9):291. doi: 10.3390/jcm7090291. J Clin Med. 2018. PMID: 30235804 Free PMC article. Review.
-
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD).Artif DNA PNA XNA. 2011 Jan;2(1):6-15. doi: 10.4161/adna.2.1.15425. Artif DNA PNA XNA. 2011. PMID: 21686247 Free PMC article.
-
Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Proteomes. 2015 Sep 16;3(3):298-327. doi: 10.3390/proteomes3030298. Proteomes. 2015. PMID: 28248273 Free PMC article.
-
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.Sci Rep. 2021 Feb 25;11(1):4722. doi: 10.1038/s41598-021-84194-w. Sci Rep. 2021. PMID: 33633318 Free PMC article.
-
Progress in therapeutic antisense applications for neuromuscular disorders.Eur J Hum Genet. 2010 Feb;18(2):146-53. doi: 10.1038/ejhg.2009.160. Epub 2009 Oct 7. Eur J Hum Genet. 2010. PMID: 19809477 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials